As President Trump's administration surpasses 100 days, investors gain insights into his economic direction, particularly regarding trade, immigration, and taxes. However, substantial changes to Medicare, which supports millions of retirees, have not emerged. Despite discussions around tweaking the program through Republican and bipartisan proposals, significant reforms are unlikely due to the program's popularity and historical difficulties in enacting change. The article highlights three potential changes, including government negotiation of drug prices, underscoring ongoing debates on healthcare sustainability in the U.S.
"President Trump's tenure has seen numerous economic and policy proposals, yet significant changes to Medicare remain elusive, and bipartisan efforts face substantial obstacles."
"Potential changes to Medicare, including government negotiation of prescription drug prices, highlight ongoing debates about the sustainability of healthcare in America."
Collection
[
|
...
]